Natco Pharma Ltd.

NSE: NATCOPHARM | BSE: 524816 | ISIN: INE987B01026 |Industry: Pharmaceuticals
|Mid-range Performer
576.50 6.70 (1.18%)
NSE Feb 20, 2019 15:31
Volume: 171.3K
 
Durability score
75 /100
High Financial Strength
Valuation score
31.3 /100
Mid Valuation
Momentum score
30.1 /100
Neutral Momentum
Market Capitalizati...
10,607.6 Cr.
High in industry
AVG Broker Target
683.7
18.59% upside
PE TTM Price to Ear...
12.9
Below industry median.
Fetching latest news from server
Poll
VOTE: What's your call on Natco Pharma Limited?
Total Votes: 59
BUY
SELL
HOLD
71.19%
20.34%
8.47%
  • Geojit BNP Paribas downgraded Natco Pharma Ltd. to Hold with a price target of 640.0 on 15 Feb, 2019.
  • Stock Price (757.00) crossed below 100 Day SMA (771.74) on 05 November, 2018
  • Stock Price (739.45) crossed above 30 Day SMA (731.36) on 30 October, 2018
  • Stock Price (757.80) crossed below 50 Day SMA (784.35) on 24 September, 2018
  • Stock Price (757.80) crossed below 150 Day SMA (786.33) on 24 September, 2018
More triggered alerts
Ex-Date Dividend Amount Dividend Type Record Date
Feb. 21, 20193.50INTERIMFeb. 22, 2019
Aug. 20, 20181.50INTERIMAug. 21, 2018
Feb. 15, 20187.00INTERIMFeb. 17, 2018
Aug. 16, 20171.25INTERIMAug. 18, 2017
Feb. 23, 20176.00INTERIMFeb. 27, 2017
All dividends by NATCOPHARM
Ex-Date Dividend Old FVNew FV Record Date
Nov. 26, 2015102-
All splits by NATCOPHARM